132 related articles for article (PubMed ID: 22546378)
1. Effects of intravesical dexpanthenol use on lipid peroxidation and bladder histology in a chemical cystitis animal model.
Bayrak O; Seckiner I; Solakhan M; Karakok M; Erturhan SM; Yagci F
Urology; 2012 May; 79(5):1023-6. PubMed ID: 22546378
[TBL] [Abstract][Full Text] [Related]
2. Chemical cystitis developed in experimental animals model: Topical effect of intravesical ozone application to bladder.
Bayrak O; Erturhan S; Seckiner I; Erbagci A; Ustun A; Karakok M
Urol Ann; 2014 Apr; 6(2):122-6. PubMed ID: 24833822
[TBL] [Abstract][Full Text] [Related]
3. Impact of intravesical hyaluronic acid treatment on bladder inflammation in interstitial cystitis rat model.
Sahiner IF; Soylu H; Ates E; Acar N; Ustunel I; Danisman A
Int Braz J Urol; 2018; 44(5):1014-1022. PubMed ID: 30044599
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of dexpanthenol and y-27632 on stricture formation in a rat model of caustic esophageal injury.
Ceylan H; Yapici S; Tutar E; Ceylan NO; Tarakçıoğlu M; Demiryurek AT
J Surg Res; 2011 Dec; 171(2):517-23. PubMed ID: 20691993
[TBL] [Abstract][Full Text] [Related]
5. Intravesical hyaluronidase causes chronic cystitis in a rat model: a potential model of bladder pain syndrome/interstitial cystitis.
Lv YS; Yao YS; Rong L; Lin ME; Deng BH; Xie Y; Huang H; Lin TX; Xu KW; Huang J
Int J Urol; 2014 Jun; 21(6):601-7. PubMed ID: 24286489
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of suplatast tosilate (IPD-1151T) in a rat cystitis model induced by intravesical hydrochloric acid.
Kirimoto T; Nakano K; Irimura K; Hayashi Y; Matsuura N; Kiniwa M; Oka T; Yoshimura N
BJU Int; 2007 Oct; 100(4):935-9. PubMed ID: 17714534
[TBL] [Abstract][Full Text] [Related]
7. Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis/painful bladder syndrome.
Chuang YC; Lee WC; Lee WC; Chiang PH
J Urol; 2009 Oct; 182(4):1393-400. PubMed ID: 19683290
[TBL] [Abstract][Full Text] [Related]
8. The ameliorating effect of melatonin on protamine sulfate induced bladder injury and its relationship to interstitial cystitis.
Cetinel S; Ercan F; Sirvanci S; Sehirli O; Ersoy Y; San T; Sener G
J Urol; 2003 Apr; 169(4):1564-8. PubMed ID: 12629416
[TBL] [Abstract][Full Text] [Related]
9. Recent developments of intravesical therapy of painful bladder syndrome/interstitial cystitis: a review.
Toft BR; Nordling J
Curr Opin Urol; 2006 Jul; 16(4):268-72. PubMed ID: 16770126
[TBL] [Abstract][Full Text] [Related]
10. Leukotriene D4 receptor antagonist montelukast alleviates protamine sulphate-induced changes in rat urinary bladder.
Çetinel S; Çanıllıoğlu YE; Çikler E; Sener G; Ercan F
BJU Int; 2011 Apr; 107(8):1320-5. PubMed ID: 20735385
[TBL] [Abstract][Full Text] [Related]
11. [Intravesical therapy of heparin and lidocaine for interstitial cystitis : a case report].
Matsuo T; Shida Y; Hayashida Y; Sakai H
Hinyokika Kiyo; 2011 Sep; 57(9):513-6. PubMed ID: 22075614
[TBL] [Abstract][Full Text] [Related]
12. The effect of intraurethral dexpanthenol in hypospadias repair: experimental rabbit study.
Karakan T; Ozcan S; Bagcioglu M; Aydın A; Doluoglu OG; Yucel MO; Adalı Y; Yagli OF
J Pediatr Urol; 2019 Aug; 15(4):375.e1-375.e5. PubMed ID: 31040076
[TBL] [Abstract][Full Text] [Related]
13. Do cystometric findings predict the results of intravesical hyaluronic acid in women with interstitial cystitis?
Daha LK; Riedl CR; Lazar D; Hohlbrugger G; Pflüger H
Eur Urol; 2005 Mar; 47(3):393-7; discussion 397. PubMed ID: 15716206
[TBL] [Abstract][Full Text] [Related]
14. [Can dexpanthenol prevent peritoneal adhesion formation? An experimental study].
Akdeniz Y; Tarhan OR; Barut I
Ulus Travma Acil Cerrahi Derg; 2007 Apr; 13(2):94-100. PubMed ID: 17682950
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 levels in female rats with protamine sulfate-induced chronic cystitis treated with hyaluronic acid.
Lv YS; Yao YS; Lin ME; Rong L; Deng BH; Huang J; Hao WP
Int J Urol; 2013 Oct; 20(10):1017-22. PubMed ID: 23379983
[TBL] [Abstract][Full Text] [Related]
16. Taurine ameliorates stress-induced degeneration of the urinary bladder.
Zeybek A; Sağlam B; Cikler E; Cetinel S; Ercan F; Sener G
Acta Histochem; 2007; 109(3):208-14. PubMed ID: 17287017
[TBL] [Abstract][Full Text] [Related]
17. Acute urinary retention and subsequent catheterization cause lipid peroxidation and oxidative DNA damage in the bladder: preventive effect of edaravone, a free-radical scavenger.
Shimizu S; Saito M; Kinoshita Y; Kazuyama E; Tamamura M; Satoh I; Satoh K
BJU Int; 2009 Sep; 104(5):713-7. PubMed ID: 19338546
[TBL] [Abstract][Full Text] [Related]
18. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis.
Morales A; Emerson L; Nickel JC; Lundie M
J Urol; 1996 Jul; 156(1):45-8. PubMed ID: 8648835
[TBL] [Abstract][Full Text] [Related]
19. Intravesical instillation of hyaluronic acid prolonged the effect of bladder hydrodistention in patients with severe interstitial cystitis.
Shao Y; Shen ZJ; Rui WB; Zhou WL
Urology; 2010 Mar; 75(3):547-50. PubMed ID: 20022087
[TBL] [Abstract][Full Text] [Related]
20. The effect of tamoxifen on bladder functions and histology, and the role of estrogen receptor beta in a rat chemical cystitis model.
Acar D; Cayan S; Aktaş S; Tek M; Akbay E
Neurourol Urodyn; 2007; 26(2):309-16. PubMed ID: 16894621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
